Obstetrics & gynaecology

Nifedipine-maintained tocolysis no benefit in perinatal outcomes

(HealthDay)—For women threatened with preterm labor, maintenance tocolysis with nifedipine is not associated with a significant reduction in adverse perinatal outcomes, according to a study published in the Jan. 1 issue ...

Oncology & Cancer

R-CHOP benefits older mantle-cell lymphoma patients

(HealthDay) -- In older patients with mantle-cell lymphoma, a rituximab-based chemotherapy regimen (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone [R-CHOP]) followed by maintenance therapy with rituximab ...

Oncology & Cancer

Bortezomib ups response, survival in multiple myeloma

(HealthDay) -- For patients with newly diagnosed multiple myeloma (MM), induction treatment with a combination of bortezomib, doxorubicin, and dexamethasone (PAD) followed by bortezomib maintenance therapy improves complete ...

page 3 from 4